On Jun. 7, 2000, President Clinton issued an Executive Memorandum that directed the Medicare program to revise its payment policy and immediately begin to explicitly reimburse providers for the cost of routine patient care associated with participation in clinical trials, and to take additional action to promote the participation of Medicare beneficiaries in clinical trials for all diseases.

This action followed an Institute of Medicine report that recommended policy changes to encourage greater use of clinical trials by older Americans.